Biosenta Inc.
ZRO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -419.70K | -523.60K | -400.00K | -367.20K | -346.30K |
| Total Depreciation and Amortization | 500.00 | 500.00 | 500.00 | 1.20K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 270.40K | 404.40K | 135.80K | 225.30K | 93.60K |
| Change in Net Operating Assets | 18.80K | 79.30K | 119.80K | 6.50K | -2.90K |
| Cash from Operations | -130.00K | -39.40K | -143.90K | -134.20K | -255.60K |
| Capital Expenditure | -18.50K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18.50K | -- | -- | -- | -- |
| Total Debt Issued | 245.20K | -- | -51.90K | 51.40K | 500.00 |
| Total Debt Repaid | -- | 56.00K | -360.00K | -- | -- |
| Issuance of Common Stock | -- | -- | 600.00K | 0.00 | 334.70K |
| Repurchase of Common Stock | -- | -359.90K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00 | 359.90K | -200.00 | 200.00 | 151.20K |
| Cash from Financing | 174.90K | 41.10K | 137.30K | 38.30K | 357.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.40K | 1.60K | -6.60K | -95.90K | 102.00K |